Medimir Systems is a health tech startup that offers a software ecosystem designed to empower physicians in making expert decisions across various medical fields. The company's slogan, "New paradigm of Clinical Decision Support," underscores its focus on providing easy-to-use clinical decision support tools that significantly enhance the quality of medical care by ensuring guideline conformity. With a foundation year of 2023 and headquartered in Germany, the company boasts a fully CE-certified product with two successful clinical trials, a publication in the Journal of Clinical Anesthesia, and an ongoing clinical study funded by the German Ministry of Health (BMG) alongside esteemed partners such as Charité Berlin and University Hospital Frankfurt. Medimir Systems, a carve-out of Börm Bruckmeier Verlag GmbH, brings with it the expertise of a specialized medical publisher with over 30 years of experience. Noteworthy clients include the Robert Koch Institut, NHS, 40+ medical associations, and big pharma companies like Pfizer, Novartis, and Roche. With a forthcoming single-user version on the horizon, Medimir Systems looks poised to disrupt the healthcare industry with its innovative approach to clinical decision support.
There is no investment information
No recent news or press coverage available for Medimir Systems.